Contents

Current Pharmaceutical Design, Volume 15 - Number 1

Editorial [Hot Topic:Nicotinamide Adenine Dinucleotide Biology and Disease(Executive Editor: W. Todd Penberthy)]

, 15(1): 1 - 2

W. Todd Penberthy


DOI: 10.2174/138161209787185779




Niacin Status, NAD Distribution and ADP-Ribose Metabolism

, 15(1): 3 - 11

James B. Kirkland


DOI: 10.2174/138161209787185823




Roles of NAD / NADH and NADP+ / NADPH in Cell Death

, 15(1): 12 - 19

Weiliang Xia, Zheng Wang, Qing Wang, Jin Han, Cuiping Zhao, Yunyi Hong, Lili Zeng, Le Tang and Weihai Ying


DOI: 10.2174/138161209787185832




Nicotinamide Phosphoribosyltransferase (Nampt): A Link Between NAD Biology, Metabolism, and Diseases

, 15(1): 20 - 28

Shin-ichiro Imai


DOI: 10.2174/138161209787185814




NAD in Skin: Therapeutic Approaches for Niacin

, 15(1): 29 - 38

Claudia A. Benavente, Myron K. Jacobson and Elaine L. Jacobson


DOI: 10.2174/138161209787185760




Cellular Regulation of SIRT1

, 15(1): 39 - 44

Jo Milner


DOI: 10.2174/138161209787185841




Pharmaceutical Strategies for Activating Sirtuins

, 15(1): 45 - 56

Anthony A. Sauve


DOI: 10.2174/138161209787185797




CD38 as a Regulator of Cellular NAD: A Novel Potential Pharmacological Target for Metabolic Conditions

, 15(1): 57 - 63

Eduardo Nunes Chini


DOI: 10.2174/138161209787185788




The Importance of NAD in Multiple Sclerosis

, 15(1): 64 - 99

W. Todd Penberthy and Ikuo Tsunoda


DOI: 10.2174/138161209787185751




The Evolution of Schizophrenia: A Model for Selection by Infection, with a Focus on NAD

, 15(1): 100 - 109

Christine L. Miller


DOI: 10.2174/138161209787185805




NAD+, Sirtuins, and Cardiovascular Disease

, 15(1): 110 - 117

Nica M. Borradaile and J. Geoffrey Pickering


DOI: 10.2174/138161209787185742




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science